fourth quarter Q4
Pharma

Lilly shines in Q4 as peers brace for 2026 slowdown

As drugmakers reported their fourth-quarter and 2025 sales, its guidance for 2026 was noteworthy as most companies are projecting a growth decline.
Kevin Dunleavy Mar 11, 2026 3:00pm
Collage poster study of businessmen picture chart arrow goes up

Orphan drug sales to surge past $400B in 2032: report

Mar 12, 2026 8:20am
Uniting for patients Helping more Americans navigate access and afford their healthcare

Uniting for patients: Navigating, accessing, and affording care

Brought to you by Patient Advocate Foundation
Legend

Legend sloughs off Carvykti threat from J&J's Tecvayli

Mar 12, 2026 2:00pm
Japan US United States Japan flag US flag

Lilly telegraphs $126M Japan production expansion

Mar 12, 2026 11:41am
Pokemon cards Pikachu

Eisai taps Pokémon app for healthy sleep awareness collab

Mar 12, 2026 11:40am
More News

FDA launches new adverse event monitoring system

Mar 12, 2026 11:04am

Lilly warns of 'impurity' in some compounded tirzepatide drugs

Mar 12, 2026 10:00am
Fierce Biotech

Building BLOC: Meet Biopharma Leaders of Color

Mar 12, 2026 10:00am

AZ recruits Joshua Jackson, Gritty to cancer screening push

Mar 11, 2026 1:00pm